Long‐term effect of first‐line injectable multiple sclerosis treatments: input of a time‐dependent propensity score - Archive ouverte HAL Access content directly
Journal Articles Pharmacoepidemiology and Drug Safety Year : 2020

Long‐term effect of first‐line injectable multiple sclerosis treatments: input of a time‐dependent propensity score

(1, 2) , (3, 4) , (3, 5) , (6) , (2, 7) , (1, 8, 9, 2)
1
2
3
4
5
6
7
8
9

Abstract

Purpose: The long-term effect of beta-interferon and glatiramer acetate on multiple sclerosis (MS) disability progression has resulted in controversial results, probably due to a lack of appropriate control of biases as raised in observational studies. In particular, the time of the therapeutic decision is difficult to define when the controls are not treated.Methods: This retrospective observational study was based on a series of patients from the MS expert center in Rennes, France. We used a time-dependent propensity score defined as the linear predictor of a Cox model estimating the hazard of being treated at each time from MS onset. The matching procedure resulted in two groups: patients matched as treated and as not yet treated. The restricted mean times (RMST) to reach a moderate level of disability or worsening of the disability were compared between the two groups in an intention-to-treat analysis.Results: Of the 2383 patients included in the study, 556 were matched as treated. The matching procedure provided a good balance of both the time-fixed and the time-dependent covariates. A slight difference was observed for the time to reach a moderate level of disability, in favor of the "not yet treated" group (difference in the RMST: -0.62 [-0.91; -0.33]) while no difference was found in terms of worsening of the disability (-0.03 [-0.24; 0.33]).Conclusion: This unexpected result is probably due to unmeasured confounders. However, this time-dependent PS warrants consideration in long-term effectiveness studies.
Fichier principal
Vignette du fichier
Lefort et al-2020-Long-term effect of first-line injectable multiple sclerosis treatments.pdf (1.71 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-02979802 , version 1 (19-11-2020)

Identifiers

Cite

Mathilde Lefort, Yohann Foucher, Rémi Lenain, Sandra Vukusic, Gilles Edan, et al.. Long‐term effect of first‐line injectable multiple sclerosis treatments: input of a time‐dependent propensity score. Pharmacoepidemiology and Drug Safety, 2020, 29 (12), pp.1680-1688. ⟨10.1002/pds.5154⟩. ⟨hal-02979802⟩
92 View
167 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More